Schizophrenia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with a schizophrenia spectrum disorder or bipolar affective disorder
- People who are currently taking antipsychotic medication (older or newer types) or lithium
- People with a Body Mass Index (BMI) of 27 or higher (this means a body weight considered above the standard healthy range for their height)
Who may not be able to join:
- People who are not able to give informed consent to participate — this will be assessed and confirmed by the person's primary mental health care provider before enrollment
- People who are currently experiencing an acute psychiatric crisis — this will be assessed and confirmed by the person's primary mental health care provider before enrollment
- People with significant difficulties with memory or thinking that may affect participation — this will be assessed and confirmed by the person's primary mental health care provider before enrollment
- People who start taking GLP-1 receptor agonist medications (a type of medication used for weight or blood sugar management) during the trial period
- People who start taking blood pressure-lowering medication during the trial period
- People who start taking diabetes medication during the trial period
- People who start taking cholesterol-lowering medication during the trial period
- Men who drink more than 14 units of alcohol per week, or women who drink more than 7 units of alcohol per week
- People with Type 1 diabetes
- People with a known heart or cardiovascular disease diagnosis
- People with a BMI below 27
- People who are pregnant
- People who are unable to do physical exercise
- People whose blood sugar level (HbA1c) is above 57 mmol/mol (7.4%) at the start of the trial
- People whose LDL cholesterol level is above 5.0 mmol/L at the start of the trial
- People whose blood pressure is above 180/100 mmHg at the start of the trial
- People with an currently active cancer diagnosis
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Professor Kjetil Retterstøl, Professor, MD, University of Oslo
Phone: +4747234028
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in Estimated Risk of Heart Disease (QRISK3); Association Between Change in Lifestyle Adherence and Change in QRISK3 Score
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.